Flushing I to store kliniske undersøgelser, hvor patientrapporterede flushing- symptomer blev målt, oplevede de patienter, der tog Pelzont, mindre flushing end de patienter, der tog nicotinsyre (depotformuleringer).
Flushing In two large clinical trials measuring patient-reported flushing symptoms, patients taking Pelzont experienced less flushing than those taking nicotinic acid (prolonged-release formulations).